Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
J Food Sci. 2022 Mar;87(3):1319-1330. doi: 10.1111/1750-3841.16079. Epub 2022 Feb 15.
Andrographis paniculata (Burm.f.) Nees (AP) is widely used in most Asian and some Western countries. However, its main effects and underlying pharmacological mechanism have not been thoroughly characterized, and its safety has not been sufficiently investigated. The present study aimed to predict and visualize the potential targets and pathways, clarify the main pharmacological effects, and investigate the toxicological properties of AP extract (APE). First, ingenuity pathway analysis (IPA) was performed to directly predict AP's therapeutic targets and pathways; main pharmacological effects of AP were speculated based on IPA results and confirmed by pharmacodynamics experiments. Rodent toxicity studies were then performed through administration of a single dose of 10 g/kg or daily doses of 2, 1, or 0.5 g/kg for 8 weeks to evaluate the safety of APE, and a similar repeated-dose study was performed using dogs with doses equal to half of the above-mentioned doses. Thus, repeated-dose toxicity studies were performed with both rodents and nonrodents. The IPA analysis and confirmatory pharmacodynamics experiments revealed that the main pharmacological effect of APE was anti-inflammation, which might be achieved by influencing various targets (e.g., AR, AKT, and BAX) and pathways (IL-8). In the single-dose toxicity test, no death or abnormal consequences were observed, and maximum tolerated dose of APE was 10 g/kg. Results from the repeated-dose toxicity tests did not reveal any obvious toxic effects from the repeated daily intragastric administration of APE at 1 g/kg for 8 weeks. In conclusion, APE at a dose of 1 g/kg did not exert any adverse effects, and administration of APE could be beneficial for the inflammatory diseases' treatment. PRACTICAL APPLICATION: Andrographis paniculata (Burm.f.) Nees is a plant that exerts clearing and detoxification effects and is widely used around the world, but a comprehensive analysis of its efficacy and safety is needed.
穿心莲(Burm.f.) Nees(AP)广泛应用于大多数亚洲国家和一些西方国家。然而,其主要作用和潜在的药理机制尚未得到彻底阐明,其安全性也未得到充分研究。本研究旨在预测和可视化 AP 的潜在靶点和途径,阐明其主要药理作用,并研究 AP 提取物(APE)的毒理学性质。首先,通过 ingenuity pathway analysis(IPA)直接预测 AP 的治疗靶点和途径;根据 IPA 结果推测 AP 的主要药理作用,并通过药效学实验进行验证。然后通过单次给予 10g/kg 或连续 8 周每天给予 2、1 或 0.5g/kg 来评价 APE 的安全性,并用剂量相当于上述剂量一半的犬进行类似的重复剂量研究,从而对啮齿类动物和非啮齿类动物进行重复剂量毒性研究。IPA 分析和验证性药效学实验表明,APE 的主要药理作用是抗炎,这可能是通过影响各种靶点(如 AR、AKT 和 BAX)和途径(IL-8)来实现的。在单次剂量毒性试验中,未观察到死亡或异常后果,APE 的最大耐受剂量为 10g/kg。重复剂量毒性试验结果表明,连续 8 周每天给予 1g/kg APE 重复灌胃给药无明显毒性作用。总之,APE 剂量为 1g/kg 时无不良反应,APE 给药可能有益于治疗炎症性疾病。
穿心莲是一种具有清热解毒作用的植物,在世界各地广泛应用,但需要对其疗效和安全性进行全面分析。